Back

Targeted proteomics improves cardiovascular risk prediction in secondary prevention: the impact of statin treatment?

European Heart Journal

20 August 2022
Organised by: Logo
Read full article
ESC Journals

Contributors

Philippe Giral
Philippe Giral

Author

You may be interested in
thumbnail
Congress Presentation
Serum proteomic profiling of carotid atherosclerosis: a population outcome study
25 August 2023
thumbnail
Webinar
Personalised secondary prevention post-ACS: the role of biomarkers
13 October 2025
thumbnail
Congress Presentation
Proteomics profiling reveals signaling pathways associated with major adverse cardiovascular events in patients with hypertrophic cardiomyopathy
28 August 2022
thumbnail
Congress Presentation
Dynamic personalized risk prediction in chronic heart failure patients: a longitudinal, clinical study of 92 biomarkers
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources